KWANGDONG PHARMACEUTICAL CO.,LTD Logo

KWANGDONG PHARMACEUTICAL CO.,LTD

Developing drugs & health goods by integrating oriental and Western medicine.

009290 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 과천시 과천대로7다길 52 광동 과천 타워, 과천시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kwangdong Pharmaceutical Co., Ltd. is a human healthcare company established in 1963, built on the founding philosophy of integrating traditional oriental medicine with modern Western science. The company researches, develops, manufactures, and markets a diverse portfolio of products. This includes prescription (ETC) and over-the-counter (OTC) drugs, alongside a wide range of consumer health goods such as functional drinks, general supplements, and traditional health foods. Kwangdong is committed to improving national health through continuous R&D, aiming to create differentiated products and new value in both pharmaceuticals and health-aid foods.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 7.1 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 4.7 MB
2025-07-30 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 6.6 KB
2025-07-25 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 6.2 KB
2025-07-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.4 KB
2025-06-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.5 KB
2025-06-26 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 5.8 KB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 969.3 KB
2025-05-29 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 5.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.9 MB
2025-05-13 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.0 KB
2025-05-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.5 KB
2025-04-30 00:00
Legal Proceedings Report
[기재정정]재해발생
Korean 12.6 KB
2025-04-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 138.2 KB
2025-04-04 00:00
Regulatory News Service
[기재정정]생산중단
Korean 13.9 KB

Automate Your Workflow. Get a real-time feed of all KWANGDONG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for KWANGDONG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.